Cases & Deals

Share

Baxter acquires Claris Injectables

July 2017

Client(s) Baxter International Inc.

Jones Day served as antitrust counsel to Baxter International Inc. in its acquisition of generic pharmaceuticals company Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.